Cardiovascular news

Anticoagulant linked to rare calciphylaxis risk

Anticoagulant linked to rare calciphylaxis risk

Calciphylaxis, a rare but serious condition causing...

Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers

Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers

Uptravi (selexipag), a prostacyclin receptor agonist...

NICE approval for new class of lipid-lowering drugs

NICE approval for new class of lipid-lowering drugs

NHS clinicians must now have the option to prescribe...

Update: GPs warned about error in cardiovascular risk calculator

Update: GPs warned about error in cardiovascular risk calculator

GPs have been advised not to use the QRISK2 cardiovascular...

'Innovative' heart failure treatment approved by NICE

'Innovative' heart failure treatment approved by NICE

A new type of drug to treat heart failure, which could...

Ticagrelor approved for long-term treatment following MI

Ticagrelor approved for long-term treatment following MI

The antiplatelet treatment Brilique (ticagrelor) can...

New once-daily fibrate/statin combination

New once-daily fibrate/statin combination

Prescribers now have the option to prescribe fenofibrate...

Ezetimibe licensed to reduce the risk of cardiovascular events

Ezetimibe licensed to reduce the risk of cardiovascular events

Ezetrol (ezetimibe) can now be prescribed to reduce...

Spironolactone hyperkalaemia warning over co-administration

Spironolactone hyperkalaemia warning over co-administration

Monitoring of blood electrolytes is essential when...

First reversal agent available for non-coumarin oral anticoagulant

First reversal agent available for non-coumarin oral anticoagulant

Idarucizumab (Praxbind) rapidly reverses the anticoagulant...

Entresto (sacubitril/valsartan): new heart failure combination tablet 'could replace ACE inhibitors as mainstay of treatment'

Entresto (sacubitril/valsartan): new heart failure combination tablet 'could replace ACE inhibitors as mainstay of treatment'

A combination of valsartan and the new drug sacubitril...

Nicorandil use restricted over ulceration risk

Nicorandil use restricted over ulceration risk

The anti-anginal nicorandil must only be used when...

New injectable antibody alirocumab enhances lipid-lowering effect of statins

New injectable antibody alirocumab enhances lipid-lowering effect of statins

Praluent (alirocumab) is the second lipid-lowering...

New lipid-lowering antibody evolocumab provides additional benefit to statins

New lipid-lowering antibody evolocumab provides additional benefit to statins

Evolocumab (Repatha) is the first in a new class of...

First approved treatment for severe orthostatic hypotension

First approved treatment for severe orthostatic hypotension

Midodrine (Bramox) provides prescribers with a licensed...

Cangrelor: new antiplatelet drug

Cangrelor: new antiplatelet drug

Kengrexal (cangrelor) has been approved to reduce the...

New oral anticoagulant edoxaban launches

New oral anticoagulant edoxaban launches

Prescribers now have an additional option for non-warfarin-based...

NICE approves apixaban for treatment of DVT and pulmonary embolism

NICE approves apixaban for treatment of DVT and pulmonary embolism

Patients can be given apixaban (Eliquis) on the NHS...

False result warning for INRatio coagulation monitoring system

False result warning for INRatio coagulation monitoring system

GPs should not use the Alere INRatio coagulation monitoring...

Oral anticoagulant accepted for NHS use after acute coronary syndromes

Oral anticoagulant accepted for NHS use after acute coronary syndromes

Rivaroxaban (Xarelto) has been accepted by NICE for...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.